Close Menu
    Trending
    • Ebola adds 60 cases in a day as Congo deaths hit 5,568
    • Dubai Airports expects over 70 million guests in 2026
    • Rand slips toward R17 as inflation and weak growth cloud outlook
    • Tüyap highlights MENA sourcing opportunities at the carpet expo in Istanbul
    • Chevron Signs 3-Year Agreement with UptimeAI, Scaling Expertise to Enhance Asset Reliability and Operational Efficiency
    • Over 9 million visitors lift Tunisia tourism income 3.4%
    • Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi
    • Ebola cases top 11,200 as Africa CDC warns of record outbreak
    • Home
    • Contact Us
    Beyrout NewsBeyrout News
    Thursday, November 19
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Beyrout NewsBeyrout News
    Home » JN.1 joins WHO’s list of Covid variants of interest amid low concerns for public health
    Health

    JN.1 joins WHO’s list of Covid variants of interest amid low concerns for public health

    December 21, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The World Health Organization (WHO) has recently designated the JN.1 coronavirus strain as a “variant of interest,” with current data indicating a low risk to public health. This classification follows the WHO’s observation of the strain’s ability to bypass immune defenses and its higher transmissibility compared to other prevalent variants. Despite these characteristics, experts, including virologist Andrew Pekosz from Johns Hopkins Bloomberg School of Public Health, emphasize that JN.1 has not been linked to more severe illness.

    JN.1 joins WHO's list of Covid variants of interest amid low concerns for public health

    Previously, JN.1 was grouped under its parent lineage, BA.2.86, but has since been recognized as a distinct variant of interest by WHO. The organization reassures that existing COVID-19 vaccines remain effective in preventing severe disease and death from JN.1 and other circulating variants. In the United States, the Centers for Disease Control and Prevention (CDC) reported that JN.1 accounted for an estimated 15% to 29% of COVID-19 cases as of December 8.

    The CDC has found no evidence of increased public health risk from JN.1 relative to other variants. It also suggests that updated vaccinations could offer protection against this variant. The discovery of the JN.1 strain of the coronavirus was first made in the United States in September, marking another evolution in the COVID-19 pandemic. Since then, the strain has garnered attention from global health authorities due to its distinct genetic makeup.

    Recent developments include the detection of seven cases in China, a week prior to the WHO’s latest announcement. This finding underscores the ongoing vigilance required in tracking and understanding COVID-19 variants as they emerge around the world. The continued monitoring and analysis of such variants are crucial for informing public health strategies and vaccine adaptations.

    Related Posts

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

    November 2, 2026

    Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

    October 28, 2026
    Latest News

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026
    © 2026 Beyrout News | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.